BRIEF

← Today's Brief
Economy  ·  32 days ago

Trump imposes 200% tariff on generic drugs

🇺🇸 UNITED STATES — The Trump administration has announced a phased plan to apply 200% tariffs on all imported generic pharmaceutical drugs. The move aims to reshape US drug supply chains but has already caused a significant slump in Indian pharmaceutical stocks. Analysts warn that such aggressive protectionism could disrupt global trade and increase costs for major exporters like India, which remains a primary supplier of generic medication to the American market.

First reported by france24.com  ·  developing for 33 days  ·  19 sourcescbsnews.comTrump plans 100% tariffs on imported generic drugs. Here's what experts say.indianexpress.com'Would expect India to be concerned': US Secretary Rubio on Trump's generic drug tariffs | World Newsthehindu.comMake in U.S. by August 2028 or pay up to 200% duty, Trump tells generic drugmakersforbes.comThe Potential Havoc Of Generic Drug Tariffstheglobeandmail.comTrump threatens tariffs on generic drugs, complicating Canada's on-shoring effortsscmp.comWhat would 200% US tariffs on generic drugs mean for China's pharmaceutical industry?nikkei.comTrump's generic drugs tariff threatens Indian pharma's top marketindependent.co.ukTrump announces plan for 200% tariffs on imported generic drugsaa.com.trTrump says US to phase in tariffs on imported generic drugs to spur domestic productionhindustantimes.com0, 100, 200: How Trump's latest generic medicines tariffs could affect Indiafrance24.comTrump announces 100% tariffs on imported generic pharmaceutical drugscnbc.comTrump plans high generic-drug tariffs in 2028 to spur U.S. production+7 more outlets
Why it matters

This policy threatens to fundamentally restructure the global generic drug market and disrupt essential healthcare supply chains.

Context

The Harmonised System of tariff classification is being utilized to categorize these specific pharmaceutical import categories for the new duty structure.